LabCorp® (NYSE: LH) today announced it will participate at the 2018 Barclays Global Healthcare Conference. LabCorp’s presentation is planned for Wednesday, March 14, 2018 at 9:30 am (ET).
A live audio webcast of the presentation will be available via the Company website at www.labcorp.com and archived for replay.
About LabCorp
LabCorp (NYSE: LH), an S&P 500 company, is a
leading global life sciences company that is deeply integrated in
guiding patient care, providing comprehensive clinical laboratory and
end-to-end drug development services. With a mission to improve health
and improve lives, LabCorp delivers world-class diagnostic solutions,
brings innovative medicines to patients faster and uses technology to
improve the delivery of care. LabCorp reported net revenues of over $10
billion in 2017. To learn more about LabCorp, visit www.labcorp.com,
and to learn more about Covance Drug Development, visit www.covance.com.
Forward-Looking Statements
This press release contains
forward-looking statements about the Company’s future operations. Each
of the forward-looking statements is subject to change based on various
important factors, including without limitation, competitive actions in
the marketplace, and adverse actions of governmental and other
third-party payers. Actual results could differ materially from those
suggested by these forward-looking statements. The Company has no
obligation to provide any updates to these forward-looking statements
even if its expectations change. Further information on potential
factors that could affect operating and financial results is included in
the Company’s Form 10-K for the year ended December 31, 2017, and
subsequent Forms 10-Q, including in each case under the heading risk
factors, and in the Company’s other filings with the SEC. The
information in this press release should be read in conjunction with a
review of the Company’s filings with the SEC including the information
in the Company’s Form 10-K for the year ended December 31, 2017, and
subsequent Forms 10-Q, under the heading MANAGEMENT’S DISCUSSION AND
ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180307006287/en/
Contacts:
Investor Contact:
Scott Frommer, 336-436-5076
Investor@LabCorp.com
or
Media
Contact:
Pattie Kushner, 336-436-8263
Media@LabCorp.com